Risk of liver disease in methotrexate treated patients

doi:10.4254/wjh.v9.i26.1092

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 26

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (15949)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

1159

WORD

363

HTML

9759

Figures (1-1)

206

Tables (1-1)

210

Sum=11697

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

484

Download

810

Sum=1294

Publishing Process of This Article

Item

Count

Browse

1108

Download

1850

Sum=2958

Sep 18, 2017 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (102)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Sep 18, 2017; 9(26): 1092-1100
Published online Sep 18, 2017. doi: 10.4254/wjh.v9.i26.1092

Open in New Tab Full Size Figure Download Figure

Figure 1 Risk of liver adverse events with methotrexate use.

Citation: Conway R, Carey JJ. Risk of liver disease in methotrexate treated patients. World J Hepatol 2017; 9(26): 1092-1100
URL: https://www.wjgnet.com/1948-5182/full/v9/i26/1092.htm
DOI: https://dx.doi.org/10.4254/wjh.v9.i26.1092